Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

The 10th Anniversary Reaxys PhD Prize Symposium: A Virtual Success

Posted on December 21st, 2020 by in Chemistry

No one anticipated that the 10th anniversary Reaxys PhD Prize Symposium would be a virtual event, but as we discussed earlier on in this blog, most gatherings of scientific researchers have had to go online this year because of COVID-19. As it turned out, the virtual symposium was a very special event in its own right.

(more…)

Looking at Emerging Trends in Telemedicine

Posted on December 17th, 2020 by in Pharma R&D

Telemedicine, once an intriguing proposition struggling to reach its potential, became an absolute necessity in 2020. In the early days of COVID-19, as medical centers labored to deal with an influx of patients while also trying to mitigate coronavirus spread, telemedicine was urgently needed as an option for providing healthcare to others at a safe distance. In the U.S., the government and providers quickly started to take measures to facilitate its use during the crisis of the pandemic.

(more…)

New Coronavirus Advisory Team Announced

Posted on November 16th, 2020 by in COVID-19

Wasting no time to start enacting his forthcoming administration’s plan for tackling COVID-19, new president-elect of the United States, Joe Biden, has unveiled his coronavirus advisory team. “Dealing with the coronavirus pandemic is one of the most important battles our administration will face, and I will be informed by science and by experts,” he stated.

(more…)

BCG – COVID-19 Hackathon Challenge Now Extended Through End of Year

Posted on October 23rd, 2020 by in COVID-19

A renewed interest in whether the BCG vaccine (for tuberculosis) could also have an application for COVID-19 has been on the rise, as evidenced by this recent Cell publication, the University of Exeter’s involvement in the BRACE Trial and ongoing general press coverage. Furthermore, the list of clinical trials focusing on this area is continuing to grow (and is available here).

(more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. …
  7. 9